Details

NameSymbolSector
SMS PHARMACEUTICALS LIMITEDSMSPHARMAPharmaceuticals
Open
234
High
235.5
Low
232.66
Close
234.72
Volume
19285
Exchange
nse
Time
14/08

Outlook

Score:  

4.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Sms Pharmaceuticals is  
Short Line
Estimated Stoploss of Sms Pharmaceuticals is ₹  
232.66
Sms Pharmaceuticals has a  
Bullishℹ
 pattern. 
Formation of  
Short Line
 candle pattern indicates the trend direction of Sms Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Sms Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Sms Pharmaceuticals is  
Downℹ
 by  

1.3

%. 
Target
Buy @ 

218.67

Sell @ 

268.05

Volume

The trade volumes of Sms Pharmaceuticals have become  
Deficientℹ
The volume trend for Sms Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Sms Pharmaceuticals is  

Down

 by  

80.18

% 

Valuation

The current market price of Sms Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
The balance sheet of Sms Pharmaceuticals is:  

Balanced

Cashflow
Sms Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 5cr

. It is  
Downℹ
 by  

82.14

%. 

(*Mar 2025)

32.27% i.e. ₹ 81cr earned in operatingℹ
49% i.e. ₹ 123cr spent in investingℹ
18.73% i.e. ₹ 47cr earned in financingℹ
0% in otherℹ
Sms Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 28cr

. It is  
Upℹ
 by  

171.79

%. 

(*Mar 2024)

37.88% i.e. ₹ 50cr earned in operatingℹ
39.39% i.e. ₹ 52cr spent in investingℹ
22.73% i.e. ₹ 30cr earned in financingℹ
0% in otherℹ
Income
The income of Sms Pharmaceuticals is  

₹ 196cr

 and  

Profit

 is :  

₹ 18cr

(*Jun 2025)

Sms Pharmaceuticals Profit is down by:  

10

% and Income is Down by:  

21.29

% 

(*Jun 2025)

The income of Sms Pharmaceuticals is  

₹ 249cr

 and  

Profit

 is :  

₹ 20cr

(*Mar 2025)

Sms Pharmaceuticals Profit is up by:  

17.65

% and Income is Up by:  

42.29

% 

(*Mar 2025)

The income of Sms Pharmaceuticals is  

₹ 175cr

 and  

Profit

 is :  

₹ 17cr

(*Dec 2024)

Sms Pharmaceuticals Profit is up by:  

30.77

% and Income is Down by:  

11.62

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.